Department of Emergency, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
J Exp Clin Cancer Res. 2009 Dec 13;28(1):152. doi: 10.1186/1756-9966-28-152.
mTOR signaling pathway and its downstream serine/threonine kinase p70S6k were frequently activated in human cancers. The dysregulation of the mTOR pathway has been found to be a contributing factor of a variety of different cancer. To investigate the role of mTOR signal pathway in the stepwise development of gastric carcinomas, we analyzed the correlations between the mTOR and P70S6K expression and clinic pathological factors and studied its prognostic role in gastric carcinomas.
mTOR and phospho-p70S6K proteins were examined by immunohistochemistry on tissue microarray containing gastric carcinomas (n = 412), adenomas (n = 47) and non-neoplastic mucosa (NNM, n = 197) with a comparison of their expression with clinicopathological parameters of carcinomas.
There was no difference of mTOR expression between these three tissues (p > 0.05). Cytoplasmic phospho(p)-P706SK was highly expressed in adenoma, compared with ANNMs (p < 0.05), whereas its nuclear expression was lower in gastric carcinomas than gastric adenoma and ANNMs (p < 0.05). These three markers were preferably expressed in the older patients with gastric cancer and intestinal-type carcinoma (p < 0.05). mTOR expression was positively correlated with the cytoplasmic and nuclear expression of p-P70S6K(p < 0.05). Nuclear P70S6K was inversely linked to tumor size, depth of invasion, lymph node metastasis and UICC staging (p < 0.05). Univariate analysis indicated that expression of mTOR and nuclear p-P70S6K was closely linked to favorable prognosis of the carcinoma patients (p < 0.05). Multivariate analysis showed that age, depth of invasion, lymphatic invasion, lymph node metastasis, Lauren's classification and mTOR expression were independent prognostic factors for overall gastric carcinomas (p < 0.05).
Aberrant expression of p-P70S6K possibly contributes to pathogenesis, growth, invasion and metastasis of gastric carcinomas. It was considered as a promising marker to indicate the aggressive behaviors and prognosis of gastric carcinomas.
mTOR 信号通路及其下游丝氨酸/苏氨酸激酶 p70S6K 在人类癌症中经常被激活。mTOR 通路的失调已被发现是多种不同癌症的一个促成因素。为了研究 mTOR 信号通路在胃癌逐步发展中的作用,我们分析了 mTOR 和 P70S6K 表达与临床病理因素之间的相关性,并研究了其在胃癌中的预后作用。
使用包含胃癌(n=412)、腺瘤(n=47)和非肿瘤性黏膜(NNM,n=197)的组织微阵列,通过免疫组织化学检测 mTOR 和磷酸化 p70S6K 蛋白,比较它们的表达与癌组织的临床病理参数。
这三种组织之间 mTOR 的表达没有差异(p>0.05)。细胞质磷酸化(p)-P706SK 在腺瘤中高表达,与 ANNMs 相比(p<0.05),而其核表达在胃癌中低于胃腺瘤和 ANNMs(p<0.05)。这三个标志物在老年胃癌患者和肠型癌中表达较好(p<0.05)。mTOR 的表达与 p-P70S6K 的细胞质和核表达呈正相关(p<0.05)。核 P70S6K 与肿瘤大小、浸润深度、淋巴结转移和 UICC 分期呈负相关(p<0.05)。单因素分析表明,mTOR 和核 p-P70S6K 的表达与癌患者的良好预后密切相关(p<0.05)。多因素分析表明,年龄、浸润深度、淋巴浸润、淋巴结转移、Lauren 分类和 mTOR 表达是影响总体胃癌患者预后的独立因素(p<0.05)。
p-P70S6K 的异常表达可能有助于胃癌的发病机制、生长、侵袭和转移。它被认为是一个有前途的标志物,可指示胃癌的侵袭性行为和预后。